In connection with the implementation of the project entitled ”Design and development of nanoparticle-RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids”, by BS Biotechna SA, under contract no. 2022/ABM/06/00005-00 for co-financing of the Commercial Project as part of the Competition for the development of targeted or personalized medicine based on medicinal products based on nucleic acids and small molecular weight compounds, the Ordering Party is conducting market research regarding the costs of purchase and delivery of the isotope gamma-P32]Adenosine 5′-triphosphate (ATP).
In order to submit an offer, please read the detailed content of the announcement included in the “delivery” section and send the completed offer form.